Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012221

Director acquired 747 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2023-08-16 Other acquisition 10b5-1 +65 $1.64 $107 20,652 D: show line 1 in the form
Young Caroline Director 2023-08-17 Other acquisition 10b5-1 +65 $1.70 $111 20,717 D: show line 2 in the form
Young Caroline Director 2023-08-18 Other acquisition 10b5-1 +65 $1.70 $111 20,782 D: show line 3 in the form
Young Caroline Director 2023-08-21 Other acquisition 10b5-1 +65 $1.68 $109 20,847 D: show line 4 in the form
Young Caroline Director 2023-08-22 Other acquisition 10b5-1 +65 $1.72 $112 20,912 D: show line 5 in the form
Young Caroline Director 2023-08-23 Other acquisition 10b5-1 +65 $1.70 $111 20,977 D: show line 6 in the form
Young Caroline Director 2023-08-24 Other acquisition 10b5-1 +27 $1.69 $46 21,004 D: show line 7 in the form
Young Caroline Director 2023-08-25 Other acquisition 10b5-1 +65 $1.70 $111 21,069 D: show line 8 in the form
Loading xslF345X05/marketforms-62532.xml…